Favorable response of ADHD with giant SEP to extended-release valproate

Brain and Development

Volumn 28, Issue 7, 2006, Pages 470-472

  Miyazaki, Masahito ^a,b   Ito, Hiromichi ^a   Saijo, Takahiko ^a   Mori, Kenji ^a   Kagami, Shoji ^a   Kuroda, Yasuhiro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Miyoshi Medical Clinic   (Japan)

Author keywords

ADHD; GABA; Giant SEP; Methylphenidate; Valproate

Indexed keywords

4 AMINOBUTYRIC ACID; GABAERGIC RECEPTOR AFFECTING AGENT; METHYLPHENIDATE; SELENICA R; VALPROIC ACID;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG PREFERENCE; DRUG RELEASE; DRUG RESPONSE; ELECTROENCEPHALOGRAM; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; MALE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ANTICONVULSANTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; DRUG DELIVERY SYSTEMS; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HUMANS; MALE; VALPROIC ACID;

EID: 33745207106     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2006.01.005     Document Type: Article

References (10)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed (1994), The Association, Washington, DC
2. Rappley M.D. Clinical practice. Attention deficit-hyperactivity disorder. N Engl J Med 352 (2005) 165-173
3. Comings D.E. Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann NY Acad Sci 931 (2001) 50-83
4. Jensen P.S., Hinshaw S.P., Swanson J.M., Greenhill L.L., Conners C.K., Arnold L.E., et al. Findings from the NIMH multimodal treatment study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr 22 (2001) 60-73
5. Physicians' Desk Reference. Oradell, NJ: Medical Economics; 1988. p. 855-6.
6. Parush S., Sohmer H., Steinberg A., and Kaitz M. Somatosensory functioning in children with attention deficit hyperactive disorder. Dev Med Child Neurol 39 (1997) 464-468
7. Gilmore R. Somatosensory evoked potential testing in infants and children. J Clin Neurophysiol 9 (1992) 324-341
8. Rothwell J.C., Obeso J.A., and Marsden C.D. On the significance of giant somatosensory evoked potentials in cortical myoclonus. J Neurol Neurosurg Psychiatry 47 (1984) 33-42
9. Miyazaki M., Hashimoto T., Nakagawa R., Yoneda Y., Tayama M., Kawano N., et al. Characteristic evoked potentials in childhood-onset Dentatorubral-Pallidoluysian Atrophy. Brain Dev 18 (1996) 389-393
10. Kanazawa O., and Nagafuji H. Valproate lowered the amplitude of visual and somatosensory evoked potentials in two cases of unrelated juvenile myoclonic epilepsy. Psychiatry Clin Neurosci 51 (1997) 425-429